SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ANG Lifesciences India informs about company updates

09 Nov 2021 Evaluate
ANG Lifesciences India has informed that the Company's Board of Directors in their meeting held on 08.11.2021, had decided to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the Company, Baddi Agro will become the Subsidiary Company of ANG Lifesciences India. Baddi Agro has manufacturing unit situated at Baddi Himachal Pradesh (formerly known as Surya Pharmaceutical) which is laced with latest machinery and located proximate to Mentha Leaf cultivation area. The details required under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 are given as an Annexure -A.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

29.87 -0.68 (-2.23%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: